Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

NCT04522050 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Gemcitabine combined with cisplatin induction chemotherapy
DRUG: concurrent chemoradiotherapy with gemcitabine

Sponsor

Fifth Affiliated Hospital, Sun Yat-Sen University